Clinical trial
Study of the Efficacy and Safety of Astaxanthin as an Adjuvant Therapy for Community Acquired Pneumonia Patients.
NCT06334874 is registered in ClinicalTrials.gov with Future University in Egypt as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of the Efficacy and Safety of Astaxanthin as an Adjuvant Therapy for Community Acquired Pneumonia Patients.
- Lead sponsor
- Future University in Egypt
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- April 1, 2024
- Completion date
- August 1, 2024
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.